Cargando…
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529273/ https://www.ncbi.nlm.nih.gov/pubmed/18554397 http://dx.doi.org/10.1186/1471-2210-8-11 |